Australia markets open in 9 hours 53 minutes

  • ALL ORDS

    7,280.60
    +49.60 (+0.69%)
     

  • AUD/USD

    0.7700
    +0.0053 (+0.69%)
     

  • ASX 200

    7,023.10
    +46.20 (+0.66%)
     

  • OIL

    61.43
    +1.25 (+2.08%)
     

  • GOLD

    1,737.80
    -9.80 (-0.56%)
     

  • BTC-AUD

    82,785.77
    +504.97 (+0.61%)
     

  • CMC Crypto 200

    1,367.49
    -8.28 (-0.60%)
     
Sign up here 📩:

Get the latest business, economy and property news, delivered straight to you.

Stay informed every day with Yahoo Finance's free Fully Briefed newsletter.

Making the case for financial stocks: strategist

Big cap financial stocks have jumped about 40% since October, but TD Ameritrade chief market strategist JJ Kinahan tells Reuters' Fred Katayama why he sees them moving even higher.

Latest stories

  • Blockchain-Based SaaS Platform ShelterZoom That Transforms Documents and Contracts into Fully Digital, Intelligent Assets, Ramps Up Staffing with New CTO and CRO Hires as Company Continues to Expand

    ShelterZoom announces two key hires. John Purvis comes on board as Chief Revenue Officer. Vince Albanese will be their Chief Technology Officer.

  • La Colombe and Steeped Coffee Bring Signature Blends to Single-Serve Customers

    Steeped Coffee, a Certified B Corp, announced the addition of La Colombe Coffee Roasters to its lineup of top brands available in its revolutionary single-serve Steeped Brewing Method. La Colombe, a pioneer of third-wave and fourth-wave coffee, now offers its signature cafe blends in fully compostable Steeped Packs. The proprietary brewing method is changing the way people view single-serve coffee, delivering all of the benefits with none of the barriers. The partnership brings quality touch-free coffee and a sought-after green business solution to hotels, offices, wholesale purchasers, and other consumers nationwide.

  • AM Best TV Presents "The Changing Relationship Between Asset Management and Diversity and Inclusion"

    In AM Best’s four-part series, "The Greening of Insurance Asset Management," top industry leaders discuss how the insurance asset management sector is adapting to meet emerging standards and expectations for climate risk and social responsibility.

  • Translation of the Articles of Association of Šiaulių Bankas AB has been updated

    Šiaulių Bankas AB, company code 112025254, domicile address Tilžės str. 149, Šiauliai, Lithuania. A comprehensive update of the English translation of the Articles of Association has been made by clarifying the terms used in the original translation (e.g. changing ‘Charter’ to ‘Articles of Association’) and correcting other translation discrepancies. An updated translation of the Bank's Articles of Association into English is available on the Bank's website. The Bank’s Articles of Association (in Lithuanian), which were approved by the General Meeting of Shareholders of the Bank on 31 March 2020, are not amended. Additional information shall be provided byDirector of the Legal Department Aurelija Geležiūnė, tel. +370 615 45571, aurelija.geleziune@sb.lt

  • Spirulina Market to Chart an Impressive Growth Trajectory; Escalating Demand for Foods with Natural Ingredients to Accelerate Market Growth: Fortune Business Insights™

    Top companies covered in spirulina market are Fraken Biochem Co., Ltd., Dongtai City Spirulina Bio-engineering Co., Algenol Biofuels Inc., DIC Corporation, Parry Nutraceuticals Ltd., Chr. Hansen Holding A/S, Fuqing King Dnarmsa Spirulina Co., Ltd., Prolgae Spirulina Supplies Pvt. Ltd., Naturex S.A., Cyanotech Corporation, Sensient Technologies Corporation, and more players profiledPune, India, April 14, 2021 (GLOBE NEWSWIRE) -- The global spirulina market size is projected to expand speedily owing to the potential benefits of spirulina for COVID-19 patients, finds Fortune Business Insights™ in its report, titled “Spirulina Market, 2021-2028”. A study published in the journal ‘Marine Biotechnology’ in February 2021 by scientists from Israel and Iceland propounds that extracts from blue-green algae can prevent COVID-19 patients from getting seriously ill. According to the scientists, a derivative of enhanced spirulina can reduce the probability of the cytokine storm triggered by the coronavirus in the lungs, which can cause acute respiratory distress, by 70%. This is possible because the extract from this alga contains a pigment-binding protein that augments anti-inflammation, anti-tumor, and anti-oxidation activities in the body. Another study, conducted in June 2020 by researchers from the Indian Institute of Science Education and Research (IISER), found that spirulina extracts can potentially inhibit the entry of SARS, MERS, and SARS-2 spike pseudotyped virus in vitro. Thus, the coronavirus outbreak is likely to boost the adoption of natural algae extracts and brighten the outlook of this market. Get Sample PDF Brochure with Impact of COVID19: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/spirulina-market-102479 Market Segmentation In terms of type, the market has been segmented into Arthrospira platensis and Arthrospira maxima. Based on form, the market has been divided into powder, tablet, and liquid. By application, the market has been clubbed into food & beverage, dietary supplements, cosmetics, and personal care. On the basis of region, the market has been analyzed across North America, Europe, Asia Pacific, South America, and the Middle East & Africa. What Does the Report Offer? The report offers an accurate computation of market figures and supplies a comprehensive analysis of the factors, trends, and restraints shaping the size, share, and growth of the market. In addition, the report encapsulates a careful study of market segments and provides a detailed examination of the regional dynamics and competitive milieu of the market. Key Driving Factor Spirulina-based Innovations by Startups to Drive Market The emergence of startups in the algae-based foods domain is driving innovation and fueling the spirulina market growth. These startups are focused on developing algae-based food items, with an aim to cater to the demands of the growing vegan population. For example, in February 2019, Prolgae, a startup based in India, created vegan chocolate bars and cookies formulated from spirulina and its extracts. Furthermore, this species of algae is also seen as a potential instrument against malnutrition, according to the Food and Agriculture Organization (FAO), prompting a few companies to produce algae-based food items and make them accessible to all. In October 2018, for instance, Proalgae announced its plans to produce high-quality, sun-dried spirulina to fight malnutrition in India and Africa. Some other startups intend to popularize this alga’s super-food status. For example, SNACK Brand, a startup launched in January 2021, will be developing farm-fresh versions of this alga in the form of clusters and powders and combine them nutrient-dense ingredients, such as flax seeds and dry fruits. List of the Leading Companies Profiled in the Global Market are: Fraken Biochem Co., Ltd. Dongtai City Spirulina Bio-engineering Co. Algenol Biofuels Inc. DIC Corporation Parry Nutraceuticals Ltd. Chr. Hansen Holding A/S Fuqing King Dnarmsa Spirulina Co., Ltd. Prolgae Spirulina Supplies Pvt. Ltd. Naturex S.A. Cyanotech Corporation Sensient Technologies Corporation Browse Detailed Summary of Research Report with TOC: https://www.fortunebusinessinsights.com/spirulina-market-102479 Regional Insights Widespread Production of Spirulina to Propel the Asia Pacific Market Growth Asia Pacific is anticipated to command the spirulina market share during the forecast period owing to the high production of the algae in Korea, China, and Indonesia. The increasing blending of this algal species with nutraceuticals in non-dairy products is expected to further support the regional market growth. The market in Europe will be majorly driven by the soaring demand for natural food colors in the continent. In countries such as France and the UK, the rising adoption of veganism and growing demand for natural, nutrient-rich ingredients in the food industry will also aid the regional market. Similar trends are foreseen in North America as well, where the preference for clean-label food and beverage products is steadily increasing. Competitive Landscape Advancements in Food Formulation Technologies to Energize the Market The dynamics of this market are being steered and shaped by the sophistication in food formulation technologies heralded by research institutions and private companies. The advent of spirulina in the food industry has opened multiple avenues of innovation in this market and key players are tapping these opportunities by stepping up their investments in research & development activities, thereby cementing their position in the market. Key Industry Development: August 2019: ScotBio announced the development of a novel technique of augmenting the amount of phycocyanin, the blue pigment found in spirulina algae. According to the company, the innovation will allow indoor-cultivated varieties of this alga a cost-effective option for food companies. Inquire Before Buying This Research Report: https://www.fortunebusinessinsights.com/enquiry/queries/spirulina-market-102479 About Us: Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. Contact Us: Fortune Business Insights™ Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India. Phone: US :+1 424 253 0390 UK : +44 2071 939123 APAC : +91 744 740 1245 Email: sales@fortunebusinessinsights.com You can also contact us/follow us on: https://www.facebook.com/FortuneBusinessInsightsPvtLtd https://twitter.com/FBInsightPvtLtd?s=20 https://www.linkedin.com/company/fortune-business-insights/

  • Global Veterinary X-ray Market to Reach $653.4 Million by 2027

    Abstract: - Global Veterinary X-ray Market to Reach $653. 4 Million by 2027. - Amid the COVID-19 crisis, the global market for Veterinary X-ray estimated at US$454. 2 Million in the year 2020, is projected to reach a revised size of US$653.New York, April 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Veterinary X-ray Industry" - https://www.reportlinker.com/p06033242/?utm_source=GNW 4 Million by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027. Computed Radiography, one of the segments analyzed in the report, is projected to record a 5.1% CAGR and reach US$260.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Direct (Capture) Radiography segment is readjusted to a revised 5.6% CAGR for the next 7-year period. - The U.S. Market is Estimated at $122.5 Million, While China is Forecast to Grow at 8.6% CAGR - The Veterinary X-ray market in the U.S. is estimated at US$122.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$140.1 Million by the year 2027 trailing a CAGR of 8.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3% and 4.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR. - Film-based Radiography Segment to Record 5.3% CAGR - In the global Film-based Radiography segment, USA, Canada, Japan, China and Europe will drive the 5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$91.9 Million in the year 2020 will reach a projected size of US$129.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$89.3 Million by the year 2027, while Latin America will expand at a 5.7% CAGR through the analysis period. - Select Competitors (Total 42 Featured) - Agfa-Gevaert GroupAllpro ImagingCanonClearvetControl-X MedicalDRE VeterinaryExamionFoveaFujifilmHeska Corporation Read the full report: https://www.reportlinker.com/p06033242/?utm_source=GNW I. METHODOLOGY II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Influencer Market Insights World Market Trajectories Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Veterinary X-ray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 2: World Historic Review for Veterinary X-ray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 3: World 15-Year Perspective for Veterinary X-ray by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 Table 4: World Current & Future Analysis for Computed Radiography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 5: World Historic Review for Computed Radiography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 6: World 15-Year Perspective for Computed Radiography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 7: World Current & Future Analysis for Direct (Capture) Radiography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 8: World Historic Review for Direct (Capture) Radiography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 9: World 15-Year Perspective for Direct (Capture) Radiography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 10: World Current & Future Analysis for Film-based Radiography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 11: World Historic Review for Film-based Radiography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 12: World 15-Year Perspective for Film-based Radiography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 13: World Current & Future Analysis for Hospitals / Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 14: World Historic Review for Hospitals / Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 15: World 15-Year Perspective for Hospitals / Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 16: World Current & Future Analysis for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 17: World Historic Review for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 18: World 15-Year Perspective for Reference Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 19: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 20: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 21: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 22: World Current & Future Analysis for Orthopedics & Traumatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 23: World Historic Review for Orthopedics & Traumatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 24: World 15-Year Perspective for Orthopedics & Traumatology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 25: World Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 26: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 27: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 28: World Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 29: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 30: World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 31: World Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 32: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 33: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 34: World Current & Future Analysis for Dental by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 35: World Historic Review for Dental by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 36: World 15-Year Perspective for Dental by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 37: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 38: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 39: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 III. MARKET ANALYSIS UNITED STATES Table 40: USA Current & Future Analysis for Veterinary X-ray by Technology - Computed Radiography, Direct (Capture) Radiography and Film-based Radiography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 41: USA Historic Review for Veterinary X-ray by Technology - Computed Radiography, Direct (Capture) Radiography and Film-based Radiography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 42: USA 15-Year Perspective for Veterinary X-ray by Technology - Percentage Breakdown of Value Sales for Computed Radiography, Direct (Capture) Radiography and Film-based Radiography for the Years 2012, 2020 & 2027 Table 43: USA Current & Future Analysis for Veterinary X-ray by End-Use - Hospitals / Clinics, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 44: USA Historic Review for Veterinary X-ray by End-Use - Hospitals / Clinics, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 45: USA 15-Year Perspective for Veterinary X-ray by End-Use - Percentage Breakdown of Value Sales for Hospitals / Clinics, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 Table 46: USA Current & Future Analysis for Veterinary X-ray by Application - Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 47: USA Historic Review for Veterinary X-ray by Application - Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 48: USA 15-Year Perspective for Veterinary X-ray by Application - Percentage Breakdown of Value Sales for Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications for the Years 2012, 2020 & 2027 CANADA Table 49: Canada Current & Future Analysis for Veterinary X-ray by Technology - Computed Radiography, Direct (Capture) Radiography and Film-based Radiography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 50: Canada Historic Review for Veterinary X-ray by Technology - Computed Radiography, Direct (Capture) Radiography and Film-based Radiography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 51: Canada 15-Year Perspective for Veterinary X-ray by Technology - Percentage Breakdown of Value Sales for Computed Radiography, Direct (Capture) Radiography and Film-based Radiography for the Years 2012, 2020 & 2027 Table 52: Canada Current & Future Analysis for Veterinary X-ray by End-Use - Hospitals / Clinics, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 53: Canada Historic Review for Veterinary X-ray by End-Use - Hospitals / Clinics, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 54: Canada 15-Year Perspective for Veterinary X-ray by End-Use - Percentage Breakdown of Value Sales for Hospitals / Clinics, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 Table 55: Canada Current & Future Analysis for Veterinary X-ray by Application - Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 56: Canada Historic Review for Veterinary X-ray by Application - Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 57: Canada 15-Year Perspective for Veterinary X-ray by Application - Percentage Breakdown of Value Sales for Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications for the Years 2012, 2020 & 2027 JAPAN Table 58: Japan Current & Future Analysis for Veterinary X-ray by Technology - Computed Radiography, Direct (Capture) Radiography and Film-based Radiography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 59: Japan Historic Review for Veterinary X-ray by Technology - Computed Radiography, Direct (Capture) Radiography and Film-based Radiography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 60: Japan 15-Year Perspective for Veterinary X-ray by Technology - Percentage Breakdown of Value Sales for Computed Radiography, Direct (Capture) Radiography and Film-based Radiography for the Years 2012, 2020 & 2027 Table 61: Japan Current & Future Analysis for Veterinary X-ray by End-Use - Hospitals / Clinics, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 62: Japan Historic Review for Veterinary X-ray by End-Use - Hospitals / Clinics, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 63: Japan 15-Year Perspective for Veterinary X-ray by End-Use - Percentage Breakdown of Value Sales for Hospitals / Clinics, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 Table 64: Japan Current & Future Analysis for Veterinary X-ray by Application - Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 65: Japan Historic Review for Veterinary X-ray by Application - Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 66: Japan 15-Year Perspective for Veterinary X-ray by Application - Percentage Breakdown of Value Sales for Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications for the Years 2012, 2020 & 2027 CHINA Table 67: China Current & Future Analysis for Veterinary X-ray by Technology - Computed Radiography, Direct (Capture) Radiography and Film-based Radiography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 68: China Historic Review for Veterinary X-ray by Technology - Computed Radiography, Direct (Capture) Radiography and Film-based Radiography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 69: China 15-Year Perspective for Veterinary X-ray by Technology - Percentage Breakdown of Value Sales for Computed Radiography, Direct (Capture) Radiography and Film-based Radiography for the Years 2012, 2020 & 2027 Table 70: China Current & Future Analysis for Veterinary X-ray by End-Use - Hospitals / Clinics, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 71: China Historic Review for Veterinary X-ray by End-Use - Hospitals / Clinics, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 72: China 15-Year Perspective for Veterinary X-ray by End-Use - Percentage Breakdown of Value Sales for Hospitals / Clinics, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 Table 73: China Current & Future Analysis for Veterinary X-ray by Application - Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 74: China Historic Review for Veterinary X-ray by Application - Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 75: China 15-Year Perspective for Veterinary X-ray by Application - Percentage Breakdown of Value Sales for Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications for the Years 2012, 2020 & 2027 EUROPE Table 76: Europe Current & Future Analysis for Veterinary X-ray by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 77: Europe Historic Review for Veterinary X-ray by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 78: Europe 15-Year Perspective for Veterinary X-ray by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 Table 79: Europe Current & Future Analysis for Veterinary X-ray by Technology - Computed Radiography, Direct (Capture) Radiography and Film-based Radiography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 80: Europe Historic Review for Veterinary X-ray by Technology - Computed Radiography, Direct (Capture) Radiography and Film-based Radiography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 81: Europe 15-Year Perspective for Veterinary X-ray by Technology - Percentage Breakdown of Value Sales for Computed Radiography, Direct (Capture) Radiography and Film-based Radiography for the Years 2012, 2020 & 2027 Table 82: Europe Current & Future Analysis for Veterinary X-ray by End-Use - Hospitals / Clinics, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 83: Europe Historic Review for Veterinary X-ray by End-Use - Hospitals / Clinics, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 84: Europe 15-Year Perspective for Veterinary X-ray by End-Use - Percentage Breakdown of Value Sales for Hospitals / Clinics, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 Table 85: Europe Current & Future Analysis for Veterinary X-ray by Application - Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 86: Europe Historic Review for Veterinary X-ray by Application - Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 87: Europe 15-Year Perspective for Veterinary X-ray by Application - Percentage Breakdown of Value Sales for Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications for the Years 2012, 2020 & 2027 FRANCE Table 88: France Current & Future Analysis for Veterinary X-ray by Technology - Computed Radiography, Direct (Capture) Radiography and Film-based Radiography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 89: France Historic Review for Veterinary X-ray by Technology - Computed Radiography, Direct (Capture) Radiography and Film-based Radiography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 90: France 15-Year Perspective for Veterinary X-ray by Technology - Percentage Breakdown of Value Sales for Computed Radiography, Direct (Capture) Radiography and Film-based Radiography for the Years 2012, 2020 & 2027 Table 91: France Current & Future Analysis for Veterinary X-ray by End-Use - Hospitals / Clinics, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 92: France Historic Review for Veterinary X-ray by End-Use - Hospitals / Clinics, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 93: France 15-Year Perspective for Veterinary X-ray by End-Use - Percentage Breakdown of Value Sales for Hospitals / Clinics, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 Table 94: France Current & Future Analysis for Veterinary X-ray by Application - Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 95: France Historic Review for Veterinary X-ray by Application - Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 96: France 15-Year Perspective for Veterinary X-ray by Application - Percentage Breakdown of Value Sales for Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications for the Years 2012, 2020 & 2027 GERMANY Table 97: Germany Current & Future Analysis for Veterinary X-ray by Technology - Computed Radiography, Direct (Capture) Radiography and Film-based Radiography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 98: Germany Historic Review for Veterinary X-ray by Technology - Computed Radiography, Direct (Capture) Radiography and Film-based Radiography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 99: Germany 15-Year Perspective for Veterinary X-ray by Technology - Percentage Breakdown of Value Sales for Computed Radiography, Direct (Capture) Radiography and Film-based Radiography for the Years 2012, 2020 & 2027 Table 100: Germany Current & Future Analysis for Veterinary X-ray by End-Use - Hospitals / Clinics, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 101: Germany Historic Review for Veterinary X-ray by End-Use - Hospitals / Clinics, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 102: Germany 15-Year Perspective for Veterinary X-ray by End-Use - Percentage Breakdown of Value Sales for Hospitals / Clinics, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 Table 103: Germany Current & Future Analysis for Veterinary X-ray by Application - Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 104: Germany Historic Review for Veterinary X-ray by Application - Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 105: Germany 15-Year Perspective for Veterinary X-ray by Application - Percentage Breakdown of Value Sales for Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications for the Years 2012, 2020 & 2027 ITALY Table 106: Italy Current & Future Analysis for Veterinary X-ray by Technology - Computed Radiography, Direct (Capture) Radiography and Film-based Radiography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 107: Italy Historic Review for Veterinary X-ray by Technology - Computed Radiography, Direct (Capture) Radiography and Film-based Radiography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 108: Italy 15-Year Perspective for Veterinary X-ray by Technology - Percentage Breakdown of Value Sales for Computed Radiography, Direct (Capture) Radiography and Film-based Radiography for the Years 2012, 2020 & 2027 Table 109: Italy Current & Future Analysis for Veterinary X-ray by End-Use - Hospitals / Clinics, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 110: Italy Historic Review for Veterinary X-ray by End-Use - Hospitals / Clinics, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 111: Italy 15-Year Perspective for Veterinary X-ray by End-Use - Percentage Breakdown of Value Sales for Hospitals / Clinics, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 Table 112: Italy Current & Future Analysis for Veterinary X-ray by Application - Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 113: Italy Historic Review for Veterinary X-ray by Application - Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 114: Italy 15-Year Perspective for Veterinary X-ray by Application - Percentage Breakdown of Value Sales for Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications for the Years 2012, 2020 & 2027 UNITED KINGDOM Table 115: UK Current & Future Analysis for Veterinary X-ray by Technology - Computed Radiography, Direct (Capture) Radiography and Film-based Radiography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 116: UK Historic Review for Veterinary X-ray by Technology - Computed Radiography, Direct (Capture) Radiography and Film-based Radiography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 117: UK 15-Year Perspective for Veterinary X-ray by Technology - Percentage Breakdown of Value Sales for Computed Radiography, Direct (Capture) Radiography and Film-based Radiography for the Years 2012, 2020 & 2027 Table 118: UK Current & Future Analysis for Veterinary X-ray by End-Use - Hospitals / Clinics, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 119: UK Historic Review for Veterinary X-ray by End-Use - Hospitals / Clinics, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 120: UK 15-Year Perspective for Veterinary X-ray by End-Use - Percentage Breakdown of Value Sales for Hospitals / Clinics, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 Table 121: UK Current & Future Analysis for Veterinary X-ray by Application - Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 122: UK Historic Review for Veterinary X-ray by Application - Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 123: UK 15-Year Perspective for Veterinary X-ray by Application - Percentage Breakdown of Value Sales for Orthopedics & Traumatology, Oncology, Cardiology, Neurology, Dental and Other Applications for the Years 2012, 2020 & 2027 SPAIN Table 124: Spain Current & Future Analysis for Veterinary X-ray by Technology - Computed Radiography, Direct (Capture) Radiography and Film-based Radiography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 125: Spain Historic Review for Veterinary X-ray by Technology - Computed Radiography, Direct (Capture) Radiography and Film-based Radiography Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 126: Spain 15-Year Perspective for Veterinary X-ray by Technology - Percentage Breakdown of Value Sales for Computed Radiography, Direct (Capture) Radiography and Film-based Radiography for the Years 2012, 2020 & 2027 Please contact our Customer Support Center to get the complete Table of ContentsRead the full report: https://www.reportlinker.com/p06033242/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • Texas police officer shot during traffic stop

    A Texas police officer was shot multiple times during a traffic stop early Wednesday, and police were searching for suspects, authorities said.

  • AKVA group ASA: Annual Report 2020

    Please find enclosed the 2020 Annual Report for AKVA group ASA and AKVA group. The Annual Report is also published on https://ir.akvagroup.com/investor-relations/financial-information/annual-reports. AKVA group’s report on Corporate Governance and Corporate Social Responsibility can be found in separate sections of the Annual Report for 2020. As stated in our Q4 report the income tax in the P&L was based on estimates. In the annual report the income tax is finally calculated. In addition, there was a change in currency gains included in net financial items. In total this resulted in net profit being NOK 4 million higher in the Annual Report 2020 compared to the Q4 report. Dated: 14 April 2021AKVA group ASA Web: www.akvagroup.com CONTACTS: Knut Nesse Chief Executive OfficerPhone:+47 51 77 85 00Mobile:+47 91 37 62 20E-mail:knesse@akvagroup.comRonny MeinkøhnChief Financial OfficerPhone:+47 51 77 85 00Mobile:+47 98 20 67 76E-mail:rmeinkohn@akvagroup.com This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment 2020 Annual Report ENG

  • Cyclica Teams Up with Top-Tier Academic Institutions to Identify a Repurposed COVID Drug

    New findings accelerated by Cyclica’s drug discovery platform suggest lung cancer drug capmatinib may improve conditions of those infected by COVID-19

  • Peapack-Gladstone Bank Now Open in Boonton, NJ

    PGC Boonton (L -R) Kristina Nitka-Thor, Daniela Oldham and Isabelle Ferreira, Boonton Peapack-Gladstone Bank Retail Associates Bedminster, NJ, April 14, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Peapack-Gladstone Financial Corporation (NASDAQ Global Select Market: PGC) is proud to announce the recent opening of its Boonton, NJ branch. Located at 104 Ely Place, the Bank’s newest retail location, and its 20th overall, will serve the communities of Boonton, Boonton Township, Mountain Lakes and the surrounding areas. The full-service branch offers personal and business banking solutions, as well as wealth management, investment banking, professional services and consumer and commercial lending. The branch is now open Monday through Friday from 9:00 am to 5:00 pm, with a late night on Thursday until 6:00 pm and Saturday hours from 9:00 am to 12:00 noon. Fully operational drive-up services, a 24-hour ATM, safe deposit boxes and night deposit services are available. The lobby is open for full time operation with COVID-19 precautions in place. For those who prefer to operate remotely, virtual appointments can be made using Zoom to open accounts or alternatively, accounts can be opened online using the Bank’s online account application found at www.pgbank.com . To celebrate the opening, and for a limited time, Peapack-Gladstone Bank is offering new clients who open a checking and money market account package at the new location, a $100 gift card to the local restaurant of their choice in the Boonton or Mountain Lakes area. Specific details and qualifiers can be found at www.pgbank.com/boonton. “I am very excited to become a part of this community,” said Daniela Oldham, vice president retail private banker, and branch manager of the Boonton location. She continued, “Like everyone else, my team and I are anxious to open our doors and connect with the residents and small businesses in the area. We’re hoping by offering a $100 gift card to a local restaurant, we can do our part to reignite the local economy and support small businesses.” For 100 years, Peapack-Gladstone Bank has proudly served its communities. And now, its Boonton area team will follow in that tradition, introducing the Peapack-Gladstone Bank brand of banking and exceptional client service to the area. About the Company Peapack-Gladstone Financial Corporation is a New Jersey bank holding company with total assets of $5.9 billion and assets under management and/or administration of $8.8 billion as of December 31, 2020. Founded in 1921, Peapack-Gladstone Bank is a commercial bank that provides innovative wealth management, investment banking, commercial and retail solutions, including residential lending and online platforms, to businesses and consumers. Peapack Private, the Bank’s wealth management division, offers comprehensive financial, tax, fiduciary and investment advice and solutions, to individuals, families, privately held businesses, family offices and not-for-profit organizations, which help them to establish, maintain and expand their legacy. Together, Peapack-Gladstone Bank and Peapack Private offer an unparalleled commitment to client service. Visit www.pgbank.com and www.peapackprivate.com for more information. Contact: Denise M. Pace-Sanders, SVP Managing Principal, Brand and Marketing Director, dpace@pgbank.com, 908.470.3322, Peapack-Gladstone Bank, 500 Hills Drive, Suite 300, Bedminster, NJ 07921. Attachment PGC Boonton

  • Insights on the Mobile Phone Accessories Global Market to 2025 - Cumulative Impact of COVID-19 - ResearchAndMarkets.com

    The "Mobile Phone Accessories Market Research Report by Product (Battery, Battery Cases, Chargers, Headphones, and Memory Card), by Distribution Mode (Offline and Online) - Global Forecast to 2025 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

  • Roth Canada Announces the Addition of Michael Tait as Head of Origination

    Roth Canada Announces the Addition of Michael Tait as Head of Origination.

  • Global Healthcare in IT Market Size & Share Will Grow to USD 662 Billion by 2026: Facts & Factors

    [225+ Pages Research Report] According to the recent research report; the global Healthcare in IT Market in 2019 was approximately USD 185 Billion. The market is expected to surge at a CAGR of 20% and is anticipated to surpass USD 662 Billion by 2026. Top market players in the market are McKesson Corporation, United Healthcare Group, Allscripts Healthcare Solutions, Inc, Athenahealth, Inc, Epic Systems Corporation, GE Healthcare and others.New York, NY, April 14, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled “Healthcare in IT Market By Product (Healthcare Provider Solutions, Non-clinical Solutions, Healthcare Payer Solutions, Provider Healthcare IT Outsourcing Services, Payer Healthcare IT Outsourcing Services, Operational Healthcare IT Outsourcing Services), By End User (Healthcare Providers, and Health care Payers), By Application (Electronic Health Records (EHRs), Computerized Provider Order Entry Systems, Electronic Prescribing Systems, PACS, Laboratory Information Systems, Clinical Information Systems, Tele-healthcare): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026”. “According to the research report, the global Healthcare in IT Market was estimated at USD 185 Billion in 2019 and is expected to reach USD 662 Billion by 2026. The global Healthcare in IT Market is expected to grow at a compound annual growth rate (CAGR) of 20% from 2019 to 2026”. Healthcare in IT Market: Overview and Definition Healthcare is undergoing dramatic transformations all over the world. Singapore is seeing an increase in the number of health-related start-ups. Many countries support mobile health programs in the transition from traditional health systems to technological treatment. The government of Mexico is working in multifaceted ways to combat diabetes, including the development of community glucose test centers and soda taxes. Saudi Arabia is reviewing and reconsidering where and how the whole healthcare system is being supported. Healthcare is undergoing dramatic transformations all over the world. Singapore is seeing an increase in the number of health-related start-ups. Many countries support mobile health programs in the transition from traditional health systems to technological treatment. The government of Mexico is working in multifaceted ways to combat diabetes, including the development of community glucose test centers and soda taxes. Saudi Arabia is reviewing and reconsidering where and how the whole healthcare system is being supported. Request Your Free Sample Report of Healthcare in IT Market @ https://www.fnfresearch.com/sample/healthcare-in-it-market (The free sample of this report is readily available on request). Our Free Sample Report Includes: 2020 Updated Report Introduction, Overview, and In-depth industry analysisCOVID-19 Pandemic Outbreak Impact Analysis Included190+ Pages Research Report (Inclusion of Updated Research)Provide Chapter-wise guidance on Request2020 Updated Regional Analysis with Graphical Representation of Size, Share & TrendsIncludes Updated List of table & figuresUpdated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue AnalysisFacts and Factors research methodology (Note: The sample of this report is updated with COVID-19 impact analysis before delivery) Key Questions Answered in this Report 1) What were the pre and post-business impacts of COVID-19 on the Healthcare in IT Market? 2) What is the market size, share of Healthcare in IT Market? 3) Who are the top market players in Healthcare in IT Market? 4) What will be the future market of Healthcare in IT Market? Key Offerings: Market Size & Forecast by Revenue | 2020−2026Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunitiesMarket Segmentation – A detailed analysis by product, by types, end-user, applications, segments, and geographyCompetitive Landscape – Top key vendors and other prominent vendors Inquire more about this report before purchase @ https://www.fnfresearch.com/inquiry/healthcare-in-it-market (You may enquire a report quote OR available discount offers to our sales team before purchase.) Healthcare in IT Market: Industry Major Market Players McKesson CorporationUnited Healthcare GroupAllscripts Healthcare Solutions IncAthenahealth IncEpic Systems CorporationGE HealthcareCerner CorporationOracle Corporation Koninklijke Philips N.VInfor Inc. To know an additional revised 2020 list of market players, request a sample report: https://www.fnfresearch.com/sample/healthcare-in-it-market Increasing geriatric population and technological advancement is driving the market of global healthcare in IT The growing geriatric population is projected to boost the use of IT services, the costs of hospital equipment, particularly for advanced treatment, and the need for home-based care services. The growing prevalence of chronic diseases such as cancer, diabetes, and heart failure also drives demand in this market for a number of IT-based services. Health IT benefits are forecast to drive business growth, such as minimizing errors in a medical facility, decreasing operating costs, and rising good performance. The acceptance of IT healthcare services has increased in recent years according to a recent AMA Survey and to data quoted in an article published in Healthcare IT News in 2020. Remote surveillance has risen from 13% in 2016 to 22% in 2019, according to the report. In addition, mobile penetration and Internet connectivity are expected to increase and encourage IT acceptance and growth in the medical sector. The number of unique mobile subscribers is expected to reach 5.8 billion by 2025, according to Mobile Economy 2020. In addition, the number of internet users grew to approximately 3,8 billion in 2019 from 250 million in 2018. Additionally, the industry is expected to push forward progress in mobile and internet technologies to enhance disease identification, treatment, and patient engagement and satisfaction. In addition to the demand for VAT and the increased costs of delivering services in the healthcare sector, digitalization will probably boost the growth of the market for IT healthcare over the 2020-2027 forecasts. On the other hand, the high integration of IT healthcare in order to solve big data management problems and their protection will also drive the many opportunities which will lead to the growth of the IT healthcare market in the forecast period. The sector is split between end-users into hospital insurers and healthcare providers. The healthcare provider segment will increase in terms of goods and services in the medical IT market at the fastest rate during the forecast period. This is because of attempts by the Government to improve the quality of medical care and the need to monitor increasing costs of health care and increase the efficiency of healthcare services. Through the implementation of electronic medical records, computerized supplier entry systems, electronic prescription systems, pacs, laboratory information systems, clinical information systems, telehealthcare, is categorized into electronic medical records. Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/healthcare-in-it-market Global Healthcare in IT Market: Growth Factors Growing geriatric population; rising hospital equipment costs, especially for advanced treatment and care; and growing demand for home healthcare services are all expected to boost IT service adoption. Furthermore, the increasing prevalence of chronic diseases such as cancer, diabetes, and heart failure is driving demand for a variety of IT-based services in this market. Healthcare IT benefits such as reducing errors in a medical facility, lowering operating costs, and increasing the rate of good results are expected to drive business growth. According to a recent AMA survey and data cited in an article published in Healthcare IT News in 2020, the acceptance of healthcare IT services has increased in recent years. According to the survey, remote monitoring for better treatment increased from 13% in 2016 to 22% in 2019. Furthermore, increasing mobile penetration and internet access is expected to drive IT adoption and development in the healthcare sector. According to the Mobile Economy 2020, the number of unique mobile subscribers was about 5.2 billion in 2019 and is projected to hit 5.8 billion by 2025. Furthermore, the number of internet users rose from 250 million in 2018 to nearly 3.8 billion in 2019. Furthermore, advances in mobile and internet-related technology for enhancing disease detection, care, and patient interaction and satisfaction are expected to drive the industry. The digitization in the healthcare industry, as well as demand for value-based care and increasing costs of providing healthcare services, will likely accelerate the growth of the healthcare IT market during the forecast period of 2020-2027. On the other hand, the high integration of the healthcare IT sector to solve issues with big data management and its security would further fuel the numerous opportunities that will lead to the growth of the healthcare IT market during the forecast period. Global Healthcare in IT Market: Segmentation The global Healthcare in IT market is segmented on the basis of product as healthcare provider solutions, non-clinical solutions, healthcare payer solutions, provider healthcare it outsourcing services, payer healthcare it outsourcing services, operational healthcare it outsourcing services. In the healthcare provider solutions segment, non-clinical solutions are projected to expand at the fastest CAGR. Technological advancements in the area of information technology have resulted in the creation of personalized software systems to meet the needs of healthcare providers. This is increasing end-user acceptance of healthcare IT solutions. Furthermore, reimbursement reductions, revenue loss due to a lack of proper documentation, and strict quality control regulations are driving the non-clinical segment sector. By End Users, the market is divided into healthcare providers and healthcare payers. Request Customized Copy of Report @ https://www.fnfresearch.com/customization/healthcare-in-it-market (We customize your report according to your research need. Ask our sales team for report customization.) North America is projected To Dominate the Global Healthcare in IT Market North America had the largest share of the global market in 2020, and this trend is expected to continue during the forecast period. The increasing use and deployment by healthcare providers of IT services and solutions to provide quality patient care at lower cost drive the regional market. In addition, specialized personnel and the rise of the number of hospitals, research centers, and universities drive market growth. Browse the full “Healthcare in IT Market by Product (Healthcare Provider Solutions, Non-clinical Solutions, Healthcare Payer Solutions, Provider Healthcare IT Outsourcing Services, Payer Healthcare IT Outsourcing Services, Operational Healthcare IT Outsourcing Services), By End User (Healthcare Providers, and Health care Payers), By Application (Electronic Health Records (EHRs), Computerized Provider Order Entry Systems, Electronic Prescribing Systems, PACS, Laboratory Information Systems, Clinical Information Systems, Tele-healthcare): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026” report at https://www.fnfresearch.com/healthcare-in-it-market. The Global Warehouse Management System market is segmented as follows: By Product: Healthcare Provider SolutionsNon-clinical SolutionsHealthcare Payer SolutionsProvider Healthcare IT Outsourcing ServicesPayer Healthcare IT Outsourcing ServicesOperational Healthcare IT Outsourcing Services By End User: Healthcare ProvidersHealth care payers By Application: Electronic Health Records (EHRs)Computerized Provider Order Entry SystemsElectronic Prescribing SystemsPACSLaboratory Information SystemsClinical Information SystemsTele-healthcare Related Reports: AI for Pharmaceutical Market: https://www.fnfresearch.com/ai-for-pharmaceutical-market Absorbable Tissue Spacer Market: https://www.fnfresearch.com/absorbable-tissue-spacer-market Sleeping Aids Market: https://www.fnfresearch.com/sleeping-aids-market Digital Pathology Market: https://www.fnfresearch.com/digital-pathology-market Plasma Therapy Market: https://www.fnfresearch.com/plasma-therapy-market-type-pure-prp-leucocyte-rich-1279 About Facts & Factors (FnF Research): Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business. Follow Us LinkedIn: https://www.linkedin.com/company/fnfresearch Follow Us Twitter: https://twitter.com/fnfresearch Contact Us: Facts & Factors USA: +1-347-989-3985 Email: sales@fnfresearch.com Web: https://www.fnfresearch.com Blog: http://fnfnewsblog.com

  • Spotify adds more livestream platforms to its virtual event listings

    Spotify began showing virtual event listings last fall, but now it's expanding that info so you can easily keep up with livestreams.

  • Manhattan Office Availability Hits Highest Level in 30 Years

    When Manhattan employers first began instructing their employees to pack up their desks and start working from home last February, many assumed that arrangement would be temporary. In fact, the amount of available office space in Manhattan is now at its highest level in at least 30 years. Many employers are reevaluating their office space needs in light of the changes they've seen over the past year.

  • Ponzi schemer Bernie Madoff has died in federal prison: AP

    Yahoo Finance’s, Adam Shapiro and Myles Udland report the death of Bernie Madoff.

  • NFL draft betting: 49ers fans take heart, odds on Mac Jones at No. 3 finally dipped a bit

    Will the 49ers really draft the Alabama quarterback?

  • The Easiest Way to Afford the Home of Your Dreams

    Fannie Mae is a type of conventional loan backed by the U.S. government. Buyers must work with a licensed contractor and have a credit score of 620 or higher. While it's possible to use a Fannie Mae HomeStyle® renovation loan to make upgrades to a rental property, it's not as easy as it once was, and Fannie Mae carefully controls the number of investors it approves.

  • Do the Top 1% Really Cheat on Their Taxes?

    Does paying little to no taxes make you a tax cheat?

  • IQDNX & IQDAX Class Action: Bronstein, Gewirtz & Grossman, LLC Reminds Infinity Q Diversified Alpha Fund Institutional Class and Infinity Q Diversified Alpha Fund Investor Class of Class Action and Lead Plaintiff Deadline: April 27, 2021

    Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Infinity Q Diversified Alpha Fund Institutional Class (NASDAQ: IQDNX) and Infinity Q Diversified Alpha Fund Investor Class (NASDAQ: IQDAX), collectively ("Infinity Q" or the "Company") and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Infinity Q securities between December 21, 2018 through February 22, 2021, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/iqdnx.